China’s Medical Technology Company Linkingmed Raised ￥40 Million in a Series A+ Round Funding Led by Grainsvalley VC

China’s medical technology company Linkingmed raised ￥40 million in a series A+ round funding led by Grainsvalley VC and followed by Binhai Capital and Shanghai Linear Venture. The investment will be use to intensify investment on product R&D and legal registration home and abroad.

Established in 2016, Linkingmed focuses on the building of tumor disease platform and data analysis. It offers automatic organ contouring, automatic radiotherapy planning, radiotherapy quality assurance tools and services to radiotherapy department, third-party imaging and radiotherapy centers to help doctor improve their efficiency and quality.